COVID-19 Impact on Global Transfection Technologies Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Transfection Technologies Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Transfection Technologies Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Lipofection
  • 1.4.3 Electroporation
  • 1.4.4 Nucleofection
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Transfection Technologies Market Share by Application: 2020 VS 2026
  • 1.5.2 Research Centers & Academic/Government Institutes
  • 1.5.3 Hospitals & Clinics
  • 1.5.4 Pharmaceutical & Biotechnology Companies
  • 1.5.5 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Transfection Technologies Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Transfection Technologies Industry
    • 1.6.1.1 Transfection Technologies Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Transfection Technologies Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Transfection Technologies Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Transfection Technologies Market Perspective (2015-2026)
• 2.2 Transfection Technologies Growth Trends by Regions
  • 2.2.1 Transfection Technologies Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Transfection Technologies Historic Market Share by Regions (2015-2020)
  • 2.2.3 Transfection Technologies Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Transfection Technologies Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Transfection Technologies Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Transfection Technologies Players by Market Size
  • 3.1.1 Global Top Transfection Technologies Players by Revenue (2015-2020)
  • 3.1.2 Global Transfection Technologies Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Transfection Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Transfection Technologies Market Concentration Ratio
  • 3.2.1 Global Transfection Technologies Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Transfection Technologies Revenue in 2019
• 3.3 Transfection Technologies Key Players Head office and Area Served
• 3.4 Key Players Transfection Technologies Product Solution and Service
• 3.5 Date of Enter into Transfection Technologies Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Transfection Technologies Historic Market Size by Type (2015-2020)
• 4.2 Global Transfection Technologies Forecasted Market Size by Type (2021-2026)

5 Transfection Technologies Breakdown Data by Application (2015-2026)

• 5.1 Global Transfection Technologies Market Size by Application (2015-2020)
• 5.2 Global Transfection Technologies Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Transfection Technologies Market Size (2015-2020)
• 6.2 Transfection Technologies Key Players in North America (2019-2020)
• 6.3 North America Transfection Technologies Market Size by Type (2015-2020)
• 6.4 North America Transfection Technologies Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Transfection Technologies Market Size (2015-2020)
• 7.2 Transfection Technologies Key Players in Europe (2019-2020)
• 7.3 Europe Transfection Technologies Market Size by Type (2015-2020)
• 7.4 Europe Transfection Technologies Market Size by Application (2015-2020)

8 China

• 8.1 China Transfection Technologies Market Size (2015-2020)
• 8.2 Transfection Technologies Key Players in China (2019-2020)
• 8.3 China Transfection Technologies Market Size by Type (2015-2020)
• 8.4 China Transfection Technologies Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Transfection Technologies Market Size (2015-2020)
• 9.2 Transfection Technologies Key Players in Japan (2019-2020)
• 9.3 Japan Transfection Technologies Market Size by Type (2015-2020)
• 9.4 Japan Transfection Technologies Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Transfection Technologies Market Size (2015-2020)
• 10.2 Transfection Technologies Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Transfection Technologies Market Size by Type (2015-2020)
• 10.4 Southeast Asia Transfection Technologies Market Size by Application (2015-2020)

11 India

• 11.1 India Transfection Technologies Market Size (2015-2020)
• 11.2 Transfection Technologies Key Players in India (2019-2020)
• 11.3 India Transfection Technologies Market Size by Type (2015-2020)
• 11.4 India Transfection Technologies Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Transfection Technologies Market Size (2015-2020)
• 12.2 Transfection Technologies Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Transfection Technologies Market Size by Type (2015-2020)
• 12.4 Central & South America Transfection Technologies Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Bio-Rad
  • 13.1.1 Bio-Rad Company Details
  • 13.1.2 Bio-Rad Business Overview and Its Total Revenue
  • 13.1.3 Bio-Rad Transfection Technologies Introduction
  • 13.1.4 Bio-Rad Revenue in Transfection Technologies Business (2015-2020))
  • 13.1.5 Bio-Rad Recent Development
• 13.2 Polyplus Transfection
  • 13.2.1 Polyplus Transfection Company Details
  • 13.2.2 Polyplus Transfection Business Overview and Its Total Revenue
  • 13.2.3 Polyplus Transfection Transfection Technologies Introduction
  • 13.2.4 Polyplus Transfection Revenue in Transfection Technologies Business (2015-2020)
  • 13.2.5 Polyplus Transfection Recent Development
• 13.3 MaxCyte
  • 13.3.1 MaxCyte Company Details
  • 13.3.2 MaxCyte Business Overview and Its Total Revenue
  • 13.3.3 MaxCyte Transfection Technologies Introduction
  • 13.3.4 MaxCyte Revenue in Transfection Technologies Business (2015-2020)
  • 13.3.5 MaxCyte Recent Development
• 13.4 Promega Corporation
  • 13.4.1 Promega Corporation Company Details
  • 13.4.2 Promega Corporation Business Overview and Its Total Revenue
  • 13.4.3 Promega Corporation Transfection Technologies Introduction
  • 13.4.4 Promega Corporation Revenue in Transfection Technologies Business (2015-2020)
  • 13.4.5 Promega Corporation Recent Development
• 13.5 Thermo Fisher Scientific
  • 13.5.1 Thermo Fisher Scientific Company Details
  • 13.5.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
  • 13.5.3 Thermo Fisher Scientific Transfection Technologies Introduction
  • 13.5.4 Thermo Fisher Scientific Revenue in Transfection Technologies Business (2015-2020)
  • 13.5.5 Thermo Fisher Scientific Recent Development
• 13.6 Affymetrix
  • 13.6.1 Affymetrix Company Details
  • 13.6.2 Affymetrix Business Overview and Its Total Revenue
  • 13.6.3 Affymetrix Transfection Technologies Introduction
  • 13.6.4 Affymetrix Revenue in Transfection Technologies Business (2015-2020)
  • 13.6.5 Affymetrix Recent Development
• 13.7 Agilent Technologies
  • 13.7.1 Agilent Technologies Company Details
  • 13.7.2 Agilent Technologies Business Overview and Its Total Revenue
  • 13.7.3 Agilent Technologies Transfection Technologies Introduction
  • 13.7.4 Agilent Technologies Revenue in Transfection Technologies Business (2015-2020)
  • 13.7.5 Agilent Technologies Recent Development
• 13.8 Altogen Biosystems
  • 13.8.1 Altogen Biosystems Company Details
  • 13.8.2 Altogen Biosystems Business Overview and Its Total Revenue
  • 13.8.3 Altogen Biosystems Transfection Technologies Introduction
  • 13.8.4 Altogen Biosystems Revenue in Transfection Technologies Business (2015-2020)
  • 13.8.5 Altogen Biosystems Recent Development
• 13.9 Boca Scientific
  • 13.9.1 Boca Scientific Company Details
  • 13.9.2 Boca Scientific Business Overview and Its Total Revenue
  • 13.9.3 Boca Scientific Transfection Technologies Introduction
  • 13.9.4 Boca Scientific Revenue in Transfection Technologies Business (2015-2020)
  • 13.9.5 Boca Scientific Recent Development
• 13.10 Chemicell
  • 13.10.1 Chemicell Company Details
  • 13.10.2 Chemicell Business Overview and Its Total Revenue
  • 13.10.3 Chemicell Transfection Technologies Introduction
  • 13.10.4 Chemicell Revenue in Transfection Technologies Business (2015-2020)
  • 13.10.5 Chemicell Recent Development
• 13.11 CytoPulse
  • 10.11.1 CytoPulse Company Details
  • 10.11.2 CytoPulse Business Overview and Its Total Revenue
  • 10.11.3 CytoPulse Transfection Technologies Introduction
  • 10.11.4 CytoPulse Revenue in Transfection Technologies Business (2015-2020)
  • 10.11.5 CytoPulse Recent Development
• 13.12 Clontech
  • 10.12.1 Clontech Company Details
  • 10.12.2 Clontech Business Overview and Its Total Revenue
  • 10.12.3 Clontech Transfection Technologies Introduction
  • 10.12.4 Clontech Revenue in Transfection Technologies Business (2015-2020)
  • 10.12.5 Clontech Recent Development
• 13.13 Deliverics
  • 10.13.1 Deliverics Company Details
  • 10.13.2 Deliverics Business Overview and Its Total Revenue
  • 10.13.3 Deliverics Transfection Technologies Introduction
  • 10.13.4 Deliverics Revenue in Transfection Technologies Business (2015-2020)
  • 10.13.5 Deliverics Recent Development
• 13.14 GE Healthcare Life Sciences
  • 10.14.1 GE Healthcare Life Sciences Company Details
  • 10.14.2 GE Healthcare Life Sciences Business Overview and Its Total Revenue
  • 10.14.3 GE Healthcare Life Sciences Transfection Technologies Introduction
  • 10.14.4 GE Healthcare Life Sciences Revenue in Transfection Technologies Business (2015-2020)
  • 10.14.5 GE Healthcare Life Sciences Recent Development
• 13.15 IBA GmbH
  • 10.15.1 IBA GmbH Company Details
  • 10.15.2 IBA GmbH Business Overview and Its Total Revenue
  • 10.15.3 IBA GmbH Transfection Technologies Introduction
  • 10.15.4 IBA GmbH Revenue in Transfection Technologies Business (2015-2020)
  • 10.15.5 IBA GmbH Recent Development
• 13.16 Lonza
  • 10.16.1 Lonza Company Details
  • 10.16.2 Lonza Business Overview and Its Total Revenue
  • 10.16.3 Lonza Transfection Technologies Introduction
  • 10.16.4 Lonza Revenue in Transfection Technologies Business (2015-2020)
  • 10.16.5 Lonza Recent Development
• 13.17 Inovio Pharmaceuticals
  • 10.17.1 Inovio Pharmaceuticals Company Details
  • 10.17.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
  • 10.17.3 Inovio Pharmaceuticals Transfection Technologies Introduction
  • 10.17.4 Inovio Pharmaceuticals Revenue in Transfection Technologies Business (2015-2020)
  • 10.17.5 Inovio Pharmaceuticals Recent Development
• 13.18 Merck KGaA
  • 10.18.1 Merck KGaA Company Details
  • 10.18.2 Merck KGaA Business Overview and Its Total Revenue
  • 10.18.3 Merck KGaA Transfection Technologies Introduction
  • 10.18.4 Merck KGaA Revenue in Transfection Technologies Business (2015-2020)
  • 10.18.5 Merck KGaA Recent Development
• 13.19 Miltenyi Biotec
  • 10.19.1 Miltenyi Biotec Company Details
  • 10.19.2 Miltenyi Biotec Business Overview and Its Total Revenue
  • 10.19.3 Miltenyi Biotec Transfection Technologies Introduction
  • 10.19.4 Miltenyi Biotec Revenue in Transfection Technologies Business (2015-2020)
  • 10.19.5 Miltenyi Biotec Recent Development
• 13.20 Oz Biosciences
  • 10.20.1 Oz Biosciences Company Details
  • 10.20.2 Oz Biosciences Business Overview and Its Total Revenue
  • 10.20.3 Oz Biosciences Transfection Technologies Introduction
  • 10.20.4 Oz Biosciences Revenue in Transfection Technologies Business (2015-2020)
  • 10.20.5 Oz Biosciences Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer